Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, has received two suspension orders from the Assistant Director, Drugs Control Administration in Telangana. The first order suspends the drug license for 5 days for a store in Nareducharla Main Road, with potential revenue loss of Rs 0.85 lakhs. The second order suspends the license for 2 days for a store in Laxmi Nagar Colony, Hydershahkote, with potential revenue loss of Rs 0.18 lakhs. The violations are under Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules, 1945. Orders were received on 30.05.2026 and the company filed this update on 31.05.2026.
The impact appears limited with a combined potential revenue loss of approximately Rs 1.03 lakhs and short suspension periods of 2-5 days. However, regulatory compliance issues at pharmacy stores could raise concerns about operational standards.